Pyrukynd
| Chemical Name | mitapivat |
| Dosage Form | Tablet (oral; 5 mg, 20 mg, 50 mg) |
| Drug Class | Pruvate kinase activators |
| System | Multiple |
| Company | Agios Pharmaceuticals |
| Approval Year | 2022 |
Indication
- For the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.